OC
Ocugen
OCGN·NASDAQMalvern PAFounded 2013100 employees
Micro CapbiotechPublicOphthalmology
Platform: OCU400 Gene
Market Cap
$0.2B
All Drugs
2
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (OCGN)
Loading OCGN stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Talarelsin | OCG-3827 | Phase 3 | 3 | KIF18A | Rett | ||
| Sotozanubrutinib | OCG-7738 | Phase 1/2 | 2 | IL-17A | CTCLAsthma |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)